To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Globe 100

No. 1 overall

Momenta: The perfect Massachusetts success story

A hit product propelled this maker of generic drugs from a money-losing operation to the top of the Globe 100 list.

Momenta Pharmaceuticals Inc. has discovered that reining in the cost of health care can be hugely profitable.

The company’s generic version of the anti-blood-clotting drug Lovenox - priced about 30 percent cheaper than the brand-name drug made by French pharmaceutical giant Sanofi SA - helped boost Momenta’s revenues by 142 percent to $283 million last year, while profits zoomed 383 percent to $180 million.

Comments